This AIV ELISA platform, as either a “competitive” or
“blocking” format, detects antibodies to influenza A viruses by allowing these antibodies to compete for
antigen binding sites with a monoclonal antibody against an epitope on the nucleoprotein that is
conserved in all influenza A viruses